Identification of a Polycystin-1 Cleavage Product, P100, That Regulates Store Operated Ca2+ Entry through Interactions with STIM1

Owen M. Woodward, Yun Li, Shengqiang Yu, Patrick Greenwell, Claas Wodarczyk, Alessandra Boletta, William B. Guggino, Feng QianPLoS 2010 · DOI

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder resulting in large kidney cysts and eventual kidney failure. Mutations in either the PKD1 or PKD2/TRPP2 genes and their respective protein products, polycystin-1 (PC1) and polycystin-2 (PC2) result in ADPKD. PC2 is known to function as a non-selective cation channel, but PC1's function and the function of PC1 cleavage products are not well understood. Here we identify an endogenous PC1 cleavage product, P100, a 100 kDa fragment found in both wild type and epitope tagged PKD1 knock-in mice. Expression of full length human PC1 (FL PC1) and the resulting P100 and C-Terminal Fragment (CTF) cleavage products in both MDCK and CHO cells significantly reduces the store operated Ca(2+) entry (SOCE) resulting from thapsigargin induced store depletion. Exploration into the roles of P100 and CTF in SOCE inhibition reveal that P100, when expressed in Xenopus laevis oocytes, directly inhibits the SOCE currents but CTF does not, nor does P100 when containing the disease causing R4227X mutation. Interestingly, we also found that in PC1 expressing MDCK cells, translocation of the ER Ca(2+) sensor protein STIM1 to the cell periphery was significantly altered. In addition, P100 Co-immunoprecipitates with STIM1 but CTF does not. The expression of P100 in CHO cells recapitulates the STIM1 translocation inhibition seen with FL PC1. These data describe a novel polycystin-1 cleavage product, P100, which functions to reduce SOCE via direct inhibition of STIM1 translocation; a function with consequences for ADPKD.

Introduction

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a leading cause of renal failure, characterized by the progressive growth of fluid-filled cysts that disrupt kidney architecture. The disease is primarily caused by mutations in PKD1 (encoding Polycystin-1, PC1) or PKD2 (encoding Polycystin-2, PC2). While PC2 is established as a calcium-permeable cation channel, the functional role of PC1—a large, complex membrane protein—remains a subject of intense investigation. PC1 is known to undergo proteolytic cleavage, but the specific functions of its resulting fragments are poorly understood. This study identifies a novel 100 kDa endogenous cleavage product, P100, and demonstrates its role as a critical regulator of calcium signaling through its interaction with the endoplasmic reticulum (ER) calcium sensor, STIM1.

Methods

The researchers employed a multidisciplinary approach to characterize the P100 fragment and its physiological impact:

  • Biochemical Identification: Western blotting with C-terminal directed antibodies was used to detect P100 in mouse embryos and postnatal kidneys. Endogenous expression was confirmed using Pkd1 knock-in mice tagged with HA or Myc epitopes.
  • Calcium Imaging: Store-operated calcium entry (SOCE) was quantified in MDCK (kidney) and CHO (ovary) cells using Fura-2 ratiometric imaging following thapsigargin-induced store depletion.
  • Electrophysiology: Xenopus laevis oocytes were used for heterologous expression to isolate and measure calcium-activated currents associated with specific PC1 fragments.
  • Protein Interaction and Localization: Co-immunoprecipitation (Co-IP) assays were performed to identify physical interactions between PC1 fragments and STIM1. Fluorescence microscopy of YFP-tagged STIM1 allowed for the visualization of STIM1 translocation and puncta formation in response to store depletion.

Key Results

Identification of the P100 Fragment

The study identified P100 as a distinct, endogenous cleavage product of PC1, likely generated by a cut within the third intracellular loop. P100 contains the final six transmembrane domains and the C-terminal tail of PC1. Interestingly, P100 expression is developmentally regulated in the kidney, peaking in the neonatal period and becoming undetectable by day 21.

P100 Inhibits Store-Operated Calcium Entry (SOCE)

Expression of full-length PC1 or the P100 fragment significantly reduced SOCE in both MDCK and CHO cell lines. In Xenopus oocytes, P100 dramatically suppressed calcium currents compared to controls. Notably, a larger cleavage product, the C-terminal fragment (CTF), did not exhibit this inhibitory effect, suggesting that the specific cleavage producing P100 is required to activate this regulatory function.

Mechanism: Inhibition of STIM1 Translocation

The researchers discovered that P100 physically binds to STIM1, as evidenced by Co-IP. Under normal conditions, store depletion triggers STIM1 to move from the bulk ER to the cell periphery, where it forms puncta and activates Orai1 calcium channels. P100 acts as a molecular tether, trapping STIM1 and preventing its translocation to the plasma membrane. This mechanism was confirmed by quantitative imaging showing a significant reduction in peripheral STIM1 puncta in P100-expressing cells.

Clinical Relevance of the R4227X Mutation

The ADPKD-causing mutation R4227X occurs within the P100 region. The study found that P100 containing this mutation fails to inhibit SOCE. This suggests that the loss of P100-mediated calcium regulation is a key factor in the calcium dysregulation that drives cyst growth in ADPKD patients.

Discussion

These findings establish P100 as a novel "calcium brake" that regulates SOCE by directly inhibiting STIM1 movement. This provides a direct mechanistic link between PC1 mutations and the abnormal calcium signaling characteristic of ADPKD. Future research is needed to identify the protease responsible for P100 generation and to determine if P100 also interacts directly with the Orai1 channel. Understanding these pathways offers potential new targets for therapeutic intervention in polycystic kidney disease.

Summary updated

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder resulting in large kidney cysts and eventual kidney failure. Mutations in either the PKD1 or PKD2/TRPP2 genes and their respective protein products, polycystin-1 (PC1) and polycystin-2 (PC2) result in ADPKD. PC2 is known to function as a non-selective cation channel, but PC1's function and the function of PC1 cleavage products are not well understood. Here we identify an endogenous PC1 cleavage product, P100, a 100 kDa fragment found in both wild type and epitope tagged PKD1 knock-in mice. Expression of full length human PC1 (FL PC1) and the resulting P100 and C-Terminal Fragment (CTF) cleavage products in both MDCK and CHO cells significantly reduces the store operated Ca(2+) entry (SOCE) resulting from thapsigargin induced store depletion. Exploration into the roles of P100 and CTF in SOCE inhibition reveal that P100, when expressed in Xenopus laevis oocytes, directly inhibits the SOCE currents but CTF does not, nor does P100 when containing the disease causing R4227X mutation. Interestingly, we also found that in PC1 expressing MDCK cells, translocation of the ER Ca(2+) sensor protein STIM1 to the cell periphery was significantly altered. In addition, P100 Co-immunoprecipitates with STIM1 but CTF does not. The expression of P100 in CHO cells recapitulates the STIM1 translocation inhibition seen with FL PC1. These data describe a novel polycystin-1 cleavage product, P100, which functions to reduce SOCE via direct inhibition of STIM1 translocation; a function with consequences for ADPKD.
BibTeX
@inproceedings{woodward2010identification,
  author = {Owen M. Woodward and Yun Li and Shengqiang Yu and Patrick Greenwell and Claas Wodarczyk and Alessandra Boletta and William B. Guggino and Feng Qian},
  title = {{Identification of a Polycystin-1 Cleavage Product, P100, That Regulates Store Operated Ca2+ Entry through Interactions with STIM1}},
  booktitle = {PLoS},
  year = {2010},
  doi = {10.1371/journal.pone.0012305},
}
Figure